Virogates
15.4
DKK
-6.67 %
VIRO
First North Denmark
Medical Equipment & Services
Health Care
1 following
-6.67%
+156.67%
+158.82%
+120%
+155.81%
+122.4%
-84.27%
-39.48%
-76.64%
www.virogates.com/investors
Virogates is a medical technology company. Business operations are conducted within the research and development of biomarkers and diagnostic instruments for the healthcare industry. The products are sold under various brands and are used in the identification, analysis, and further treatment of diseases, mainly cardiovascular diseases, cancer, and neurological diseases. The company was established in 2001 and is headquartered in Birkerød.
Revenue
5.58M
EBIT %
-225.27 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Denmark
VIRO
Daily low / high price
12.4 / 17.1
DKK
Market cap
119.15M DKK
Turnover
239.04K DKK
Volume
16K
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| N.P. Louis-Hansen APS. | 25.8 % | 25.8 % |
| 4AM APS | 10.3 % | 10.3 % |
| Kim Ginnerup APS | 10.3 % | 10.3 % |
ShowingAll content types
ViroGates announces its Interim Report for Q1-Q3 2024: Revenues are disappointing, but strategic refocusing will pave the way for future growth
ViroGates announces a distribution agreement with suPAR Health and a directed issue of shares to suPAR Remedy LLC
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools